A director at AMG Critical Materials N.V maiden bought 3,000 shares at 25.930EUR and the significance rating of the trade was 72/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the las...
GTT: Monthly disclosure of the total number of voting rights and shares composing the share capital Monthly disclosure of the total number of voting rights and shares composing the share capital Articles L. 233-8-II of the French Commercial Code and 223-16 of the General Regulation of the Autorité des Marchés Financiers Saint-Rémy-lès-Chevreuse, November 6, 2025 DateTotal number of sharesTheoretical total number of voting rights1Net total number of voting rights2October 31, 202537,117,77237,117,77237,064,515 Investor Relations Contact / 64 1 Calculate...
GTT : Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social Articles L. 233-8-II du Code de commerce et 223-16 du Règlement général de l’Autorité des marchés financiers Saint-Rémy-lès-Chevreuse, le 6 novembre 2025 DateNombre total d’actions composant le capitalNombre total de droits de vote théoriques1Nombre total de droits de vote nets231 octobre 202537 117 77237 117 77237 064 515 Contact Relations Investisseurs : / 64 ...
Adecco: 3Q25 strong beat; outlook 4Q25 seems in line. Air France-KLM: Bit light but outlook unchanged. ArcelorMittal: In line 3Q25, supportive medium-term outlook. AMG: 3Q25 EBITDA beats by 5%, ‘only' modest FY guidance increase might disappoint. BAM Group: Maintains outlook as expected. CTP: Guidance at the lower end due to a missed deal in Romania. Strong operational trends continued. IMCD: 3Q showed pressure on gross margin. Kinepolis: US peer AMC; better revenues and EBITDA in ...
Transgene to Showcase Potential of Proprietary VacDesignR® Computational Tool to Optimize Individualized Therapeutic Cancer Vaccines Computational tool improves recombinant virus design efficiency and yield. This innovative in-house development is a key component of Transgene’s INTV1 platform. Poster to be presented at ESMO-AI 2025 Strasbourg, France, November 6, 2025, 8:30 a.m. CET – Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer today announced it will present a poster on its proprietary VacDesig...
Transgene présentera le potentiel de VacDesignR®, un outil bio-informatique breveté pour optimiser les vaccins thérapeutiques individualisés contre le cancer Cet outil informatique améliore la conception et le rendement de production des virus recombinants de la plateforme myvac®. Ce développement interne innovant est une composante essentielle de plateforme de VTIN1 de Transgene. Présentation d’un poster à l’ESMO-AI 2025 Strasbourg, France, le 6 novembre 2025, 8 h 30 – Transgene (Euronext Paris : TNG), société de biotechnologie qui conçoit et développe des immunothérapies contre le ...
AMG Reports Strong Third Quarter 2025 Results Amsterdam, 5 November 2025 (Regulated Information) --- AMG Critical Materials N.V. (“AMG”, EURONEXT AMSTERDAM: “AMG”) reports third quarter 2025 revenue of $435 million, a 22% increase compared to the third quarter 2024 revenue of $356 million. AMG achieved an adjusted EBITDA of $64 million, a 58% increase compared to the third quarter of 2024 adjusted EBITDA of $40 million, driven primarily by the AMG Technologies segment. Dr. Heinz Schimmelbusch, Chairman of the Management Board and CEO, said, “Our third quarter performance remained strong, d...
ASSYSTEM : Informations relatives au nombre total de droits de vote et d'actions composant le capital social au 31 octobre 2025 Informations relatives au nombre d’actions composant le capital social et au nombre total de droits de vote correspondants Paris La Défense, le 5 novembre 2025 – Assystem S.A. (ISIN : FR0000074148 - ASY), annonce aujourd'hui, conformément à l’article L. 233-8 II du Code de commerce et à l’article 223-16 du Règlement général de l’Autorité des marchés financiers, le nombre d’actions composant son capital social et le nombre total de droits de vote correspondants à l...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.